MEAGHAN ANN MIZE

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant ATHENS, GA NPI 1568005692

General Payments — all program years on this page

$1,157.27

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 52
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $451.12 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $451.1222

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $171.549
2022 $181.1610
2023 $353.4511
2024 $451.1222

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087131570 Novartis Pharmaceuticals Corporation $23.10 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087131582 Novartis Pharmaceuticals Corporation $23.08 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089458040 Daiichi Sankyo Inc. $26.61 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104666625 AstraZeneca Pharmaceuticals LP $24.43 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104730297 AstraZeneca Pharmaceuticals LP $29.61 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105334817 AstraZeneca Pharmaceuticals LP $18.82 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114344813 Regeneron Healthcare Solutions, Inc. $31.05 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116451609 GlaxoSmithKline, LLC. $19.39 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117177357 Mirati Therapeutics, Inc. $14.83 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120235778 EMD Serono, Inc. $17.69 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126838048 Genmab U.S., Inc. $21.33 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126838050 Genmab U.S., Inc. $16.53 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127053627 Kyowa Kirin, Inc. $15.11 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139748268 GENZYME CORPORATION $19.46 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139748300 GENZYME CORPORATION $20.51 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141298975 Incyte Corporation $14.56 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141440937 SOBI, INC $14.45 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141903556 Merck Sharp & Dohme LLC $23.89 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142969419 Stemline Therapeutics Inc. $14.89 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143496752 Aveo Pharmaceuticals, Inc. $20.00 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144980474 Takeda Pharmaceuticals U.S.A., Inc. $21.90 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146405999 Cumberland Pharmaceuticals, Inc. $19.88 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.